Stocks · News reference

Why Is Celularity Stock Gaining Thursday?

Aug 27, 2026, 5:42 PMVandana Singh

Celularity (CELU) stock surged 131% following a $300M U.S. manufacturing collaboration with MuseCell Innovations in New Jersey.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 27, 2026, 2:34 PMBenzinga Newsdesk
Reported Earlier: Celularity And MuseCell Innovations Expand U.S. Manufacturing Collaboration, With Potential For $300M+ In Purchases Over Five Years
Collaboration is intended to expand U.S. manufacturing of Dezawa MuseCells® initially across qualified perinatal sources using the licensed Dezawa Method™ and manufacturing of DMC derived products, including Dezawa
CELU
BenzingaAug 27, 2026, 2:18 PMBenzinga Newsdesk
Celularity shares are trading higher after the company announced an additional U.S.-based manufacturing collaboration under which Celularity will undertake activities to establish U.S. production of Dezawa MuseCells at Celularity’s Florham Park, New Jersey facility.
CELU
BenzingaAug 27, 2026, 1:03 PMBenzinga Newsdesk
Celularity To Begin U.S. Production Of MuseCell Innovations' Dezawa MuseCells At Its New Jersey Facility
The initial program is designed to establish manufacturing capability for MCI-authenticated DMC preparations. Under the MCI platform, a preparation is authenticated as a DMC product through perinatal, bone marrow or
CELU